4//SEC Filing
Akirov Alfred 4
Accession 0001144204-13-015174
CIK 0001006281other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:00 PM ET
Size
5.8 KB
Accession
0001144204-13-015174
Insider Transaction Report
Form 4
Akirov Alfred
Director
Transactions
- Sale
Common Stock
2013-03-12$5.70/sh−10,000$57,000→ 5,027,713 total(indirect: By Corporation)
Footnotes (1)
- [F1]All sales reported on this Form 4 were made by Alrov (Israel) Ltd.("Alrov Israel") and the column in Table 1 disclosing the amount of securities beneficially owned following the reported transaction includes 686,046 shares of our common stock held by Technorov Holdings (1993) Ltd. ("Technorov"). Alrov Israel owns 100% of Al-Rov Technologies Holdings LTD, the holder of 80% of Technorov. The reporting person is the Chairman of Alrov Israel and the Chief Executive Officer of Technorov, and has the power to control their respective investment decisions. Alrov Israel is an Israeli publicly-traded company that is listed on the Tel Aviv Stock Exchange. The reporting person disclaims beneficial ownership of the securities of the Issuer held by Alrov Israel and Technorov, except to the extent of his proportional pecuniary interest therein.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001434514
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:00 PM ET
- Size
- 5.8 KB